UPDATE 1-Ackman: Valeant's main problem is PR, not fraud

BOSTON, Oct 30 (Reuters) - Hedge fund mogul William Ackman told his investors on Friday that he was confident in his bet on Valeant Pharmaceuticals but faulted the company for a weak response to...